An Introduction to Vaccines: An Old Problem in a New Setting
The story of modern vaccine development begins with Jenner 200 years ago and today smallpox has been completely eradicated. This unique and remarkable achievement has been accomplished in part because vaccinia meets so well the requirement of a good vaccine (Table 1). No less important, however, has been the mobilisation of social, political and economic resources around the world coordinated by the World Health Organisation. The will to do the job and an effective strategy coupled to an almost ideal vaccine made this possible.
KeywordsRespiratory Syncytial Virus Peptide Vaccine Vaccine Design Human Rabies Ideal Vaccine
Unable to display preview. Download preview PDF.
- Barteling JA (1988) Possibilities and limitations of synthetic peptide vaccines in biotechnology in Advances in Biotechnological Process 10 Ed. M. Mizrahi, Alan Liss, New York.Google Scholar
- Bruggemann M, Neuberger M S (1988) Novel antibodies by genetic manipulation progress in allergy. 45: 91–105Google Scholar
- Perrin LH, Simitsek P, Srivastava I (1988) Development of malaria vaccines. Trop Geogr Med 40: 56–521Google Scholar
- Rothbard J (1989) High degeneracy of HLA DR peptide interactions:possible ramifications in vaccine design. This symposium.Google Scholar
- Zuckerman AJ, (1988) The development of novel hepatitis B vaccines. Biochem Soc Symp 53: 39–49Google Scholar